ImmuCell Corporation ICCC

9.93 (0.04) (0.40%) as of 25 Sep
Market cap
$90.6M
P/E
117×
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
43.18 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
2.63 3.92 3.52 2.56 2.80 3.16 2.70 2.22 1.59 2.01
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 44.02
P/Operating CF
(67.59) 123.76 (279.67) (753.60) 274.58 103.31 (38.67) (53.58) (13,568.09) 115.05
P/B ratio
1.28 1.73 1.78 1.21 1.52 1.86 1.65 1.55 1.53 2.05
EV/Sales
1.84 4.42 4.18 2.53 2.90 3.10 2.94 2.85 1.84 2.20
EV/EBITDA
10.36 69.66 504.64 26.13 41.57 21.89 278.42 0.00 44.82 13.72
EV/FCF
(4.64) (2.79) (21.33) (49.11) (16.40) (36.41) (9.92) (7.58) (472.81) 48.22
Current Ratio
6.97 3.64 2.50 5.29 5.50 6.42 4.56 2.73 3.41 4.26
Net Debt/EBITDA
(4.50) 7.79 79.61 (0.26) 1.45 (0.38) 22.61 (3.65) 6.22 1.19
Debt/Equity
0.15 0.38 0.45 0.29 0.34 0.28 0.34 0.48 0.38 0.34
ROE
3.35% (0.78%) (10.24%) (5.11%) (3.57%) (0.26%) (7.92%) (20.86%) (8.21%) (3.81%)
ROA
2.59% (0.57%) (6.93%) (3.63%) (2.59%) (0.18%) (5.58%) (13.03%) (4.85%) (2.37%)
ROIC
4.59% (0.53%) (3.12%) (2.08%) (2.89%) 0.51% (4.13%) (9.98%) (2.99%) 3.19%
Return on Tangible Assets
2.30% (0.53%) (7.77%) (3.60%) (2.78%) (0.19%) (6.34%) (16.57%) (5.99%) (3.06%)
Average Days of Receivables
37.95 47.03 30.97 43.55 42.75 51.10 34.57 45.66 51.95 45.14
Earnings Yield
2.32% (0.48%) (6.10%) (3.69%) (2.35%) (0.13%) (5.00%) (15.00%) (5.63%) (1.71%)
Free Cash Flow Yield
(15.02%) (40.41%) (5.57%) (2.02%) (6.32%) (2.70%) (10.98%) (16.94%) (0.25%) 2.27%
Free Cash Flow per Share
(0.89) (3.34) (0.39) (0.10) (0.38) (0.22) (0.71) (0.85) (0.01) 0.14
Book value per Share
4.67 4.77 3.96 4.25 3.92 4.29 3.92 3.23 3.37 3.00
Free Cash Flow
(3.78) (16.54) (2.15) (0.71) (2.71) (1.64) (5.51) (6.56) (0.10) 1.26
EV/EBIT
19.69 0.00 0.00 0.00 0.00 231.90 0.00 0.00 0.00 36.87
Other line items

Show all line items

Columns are period end dates